Lifevantage (NASDAQ:LFVN) Share Price Passes Above Two Hundred Day Moving Average – What’s Next?

Lifevantage Corporation (NASDAQ:LFVN) shares passed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of $5.71 and traded as high as $6.31. Lifevantage shares last traded at $6.25, with a volume of 125,559 shares changing hands.

Analysts Set New Price Targets

Several research analysts have recently weighed in on the company. Lake Street Capital downgraded Lifevantage from a “buy” rating to a “hold” rating and set a $5.00 target price for the company. in a research note on Thursday, May 7th. Weiss Ratings raised shares of Lifevantage from a “hold (c-)” rating to a “hold (c)” rating in a report on Tuesday, May 26th. Two analysts have rated the stock with a Hold rating, Based on data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $5.00.

Lifevantage Stock Up 0.2%

The stock has a market capitalization of $78.88 million, a PE ratio of 13.89 and a beta of 0.73. The company has a 50-day moving average of $6.68 and a 200 day moving average of $5.71.

Lifevantage (NASDAQ:LFVN) last posted its quarterly earnings data on Wednesday, May 6th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.16 by ($0.04). The firm had revenue of $43.72 million during the quarter, compared to analyst estimates of $47.77 million. Lifevantage had a net margin of 2.94% and a return on equity of 23.89%. As a group, equities analysts predict that Lifevantage Corporation will post 0.6 EPS for the current fiscal year.

Lifevantage Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, June 15th. Stockholders of record on Monday, June 1st were issued a dividend of $0.05 per share. The ex-dividend date of this dividend was Monday, June 1st. This is a positive change from Lifevantage’s previous quarterly dividend of $0.04. This represents a $0.20 dividend on an annualized basis and a dividend yield of 3.2%. Lifevantage’s payout ratio is currently 44.44%.

Hedge Funds Weigh In On Lifevantage

Several hedge funds and other institutional investors have recently modified their holdings of LFVN. JPMorgan Chase & Co. lifted its stake in shares of Lifevantage by 870.2% in the second quarter. JPMorgan Chase & Co. now owns 5,016 shares of the company’s stock worth $66,000 after buying an additional 4,499 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. purchased a new stake in Lifevantage during the 2nd quarter valued at about $76,000. BNP Paribas Financial Markets raised its holdings in Lifevantage by 2,555.8% in the 2nd quarter. BNP Paribas Financial Markets now owns 6,135 shares of the company’s stock valued at $80,000 after acquiring an additional 5,904 shares during the last quarter. Cubist Systematic Strategies LLC acquired a new stake in Lifevantage in the 1st quarter valued at about $97,000. Finally, New York State Common Retirement Fund purchased a new position in Lifevantage in the 2nd quarter worth approximately $102,000. 35.32% of the stock is owned by hedge funds and other institutional investors.

Lifevantage Company Profile

LifeVantage Corporation is a publicly traded company that develops, markets and distributes nutritional supplements, skincare products and weight-management solutions through a direct-selling business model. The company’s flagship offering, Protandim®, is formulated to activate the Nrf2 pathway, which is associated with cellular defense processes. LifeVantage also markets the PhysIQ® line for metabolism and body composition support and the TrueScience® skincare regimen, targeting a range of health and wellness needs.

Founded in 1999 and headquartered in Sandy, Utah, LifeVantage combines research in nutrigenomics with a network of independent distributors to bring its products to market.